The Global Market for Human Reproductive Technologies is Projected to Reach US$23.1 Billion by 2020
Advanced ART Methods to Treat Infertility to Drive the
Human Reproductive Technologies Market, According to a New Report by Global Industry Analysts, Inc.
GIA launches comprehensive
analysis of industry segments, trends, growth drivers, market share, size and
demand forecasts on the global Human Reproductive Technologies market. The
global market for Human Reproductive Technologies is projected to reach US$23.1
billion by 2020, driven by rising infertility rates due to advancing
maternal age among older women, and nutritional deficiencies, lifestyle stress
and exposure to toxic environmental agents in younger women.
The Human reproductive
technologies market is broadly divided into contraceptive technologies (drugs
& devices), and drugs and procedures to treat infertility. Delayed
parenthood decisions, rising rates of infertility due to lifestyle factors such
as smoking and alcohol abuse, increased patient awareness about newer
contraceptive devices and ART methods, growing affluence and adoption of
expensive healthcare services, are all expected to boost the global market for
human reproductive technologies. Contraceptive technologies are witnessing
rapid growth in the market, driven by early onset of sexual activity, social awareness
over the importance of preventing unwanted teenage pregnancies, delayed parenthood
decisions among the growing base of working women, and the need to prevent
STDs. Oral contraceptive pills and male condoms are popular types of
contraception, on account of higher patient awareness, and easy availability
and access. Hormonal transdermal and subdermal patches, and highly effective
intrauterine devices are also gaining in importance. Factors driving the IUD
market include high effectiveness and lesser side effects when compared to
other means of contraception.
About
10-13% of couples globally have fertility problems. Infertility is primarily
addressed by drugs as the first line of treatment, followed by Assisted
Reproductive Technology (ART). ART, which uses in-vitro techniques and related
methods, represents a thriving market. The market is dominated by In-Vitro
Fertilization (IVF), IntraUterine
Insemination (IUI), Intra Cytoplasmic Sperm Injection (ICSI), and the rarer
techniques of Zygote IntraFallopian Transfer and Gamete IntraFallopian
Transfer. IVF remains one of the most popular ART methods. An estimated 1.5
million IVF cycles are performed worldwide every year, of which about 42% of
cycles are conducted in Europe. Factors restraining the IVF market include high treatment costs, the
need for multiple cycles that adds up to the cost, lower awareness levels in
developing economies such as Nigeria, and the risk of multiple pregnancies (twins,
triplets & quadruplets). With the use of modern, milder ovulatory drugs and
the implantation of only one embryo, the risk of multiple births has declined considerably.
As stated by the new
market research report on Human
Reproductive Technologies, the United States represents the largest
market worldwide. Research and Development of innovative contraceptives, and
technological advancements in ART drive the U.S. market. Asia-Pacific ranks as the
fastest growing market, with a CAGR of 3.8% over the analysis period. The growth
in the region is driven by rising population, increased awareness of
contraceptive technologies, and a thriving fertility tourism industry.
Major players covered in
the report include Ansell
Limited, Agile Therapeutics, Bayer HealthCare, Church & Dwight Co., Inc., Cipla
Limited, CellCura ASA, Cook Medical, CooperSurgical, Ferring Pharmaceuticals,
Fuji Latex Co., Ltd., Genea Biomedx, Merck KGAA, Okamoto Industries, Pfizer
Inc., Progyny, Inc., Reckitt Benckiser Group Plc., Sanofi, Teva Pharmaceutical
Industries Ltd., and The Female Health Company, among others.
The research report titled
“Human Reproductive Technologies: A Global Strategic
Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of the market trends, market issues, growth drivers, and strategic
industry activity of global companies.
The report provides market estimates and projections for major
geographic markets, including the US, Canada, Japan, Europe (France, Germany,
Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and
Rest of Asia-Pacific), Middle East & Africa, and Latin America (Brazil
& Rest of Latin America).
Comments
Post a Comment